Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphoma (Q77392229)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9766801%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9766801%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

J C Yau

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9766801%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

C Germond

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9766801%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S Gluck

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9766801%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

C Cripps

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9766801%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

S Verma

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9766801%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

B F Burns

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9766801%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

T M Koski

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9766801%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

D C Lister

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9766801%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

G D Goss

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9766801%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 October 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9766801%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Hematology

5 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9766801%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9766801%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9766801%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

156-160

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9766801%20AND%20SRC:MED&resulttype=core&format=json

A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project

5 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199810%2959%3A2%3C156%3A%3AAID-AJH9%3E3.0.CO%3B2-X

The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199810%2959%3A2%3C156%3A%3AAID-AJH9%3E3.0.CO%3B2-X

Effect of age on therapeutic outcome in advanced diffuse histiocytic lymphoma: the Southwest Oncology Group experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199810%2959%3A2%3C156%3A%3AAID-AJH9%3E3.0.CO%3B2-X

Non-Hodgkin's lymphomas in 137 patients aged 70 years or older: a retrospective European Organization for Research and Treatment of Cancer Lymphoma Group Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199810%2959%3A2%3C156%3A%3AAID-AJH9%3E3.0.CO%3B2-X

Clinical trial of prednimustine, Leo-1031 (NSC-134087), in patients with non-Hodgkin lymphomata and chronic lymphocytic leukaemia previously treated with steroids and alkylating agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199810%2959%3A2%3C156%3A%3AAID-AJH9%3E3.0.CO%3B2-X

Non-Hodgkin's lymphomas in the elderly: prospective studies with specifically devised chemotherapy regimens in 66 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199810%2959%3A2%3C156%3A%3AAID-AJH9%3E3.0.CO%3B2-X

Combination Chemotherapy Specifically Devised for Elderly Patients with Unfavorable Non-Hodgkin's Lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199810%2959%3A2%3C156%3A%3AAID-AJH9%3E3.0.CO%3B2-X

A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199810%2959%3A2%3C156%3A%3AAID-AJH9%3E3.0.CO%3B2-X

Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199810%2959%3A2%3C156%3A%3AAID-AJH9%3E3.0.CO%3B2-X

In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199810%2959%3A2%3C156%3A%3AAID-AJH9%3E3.0.CO%3B2-X

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199810%2959%3A2%3C156%3A%3AAID-AJH9%3E3.0.CO%3B2-X

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199810%2959%3A2%3C156%3A%3AAID-AJH9%3E3.0.CO%3B2-X

Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199810%2959%3A2%3C156%3A%3AAID-AJH9%3E3.0.CO%3B2-X

Aggressive Chemotherapy for Diffuse Histiocytic Lymphoma in the Elderly: Increased Complications with Advancing Age

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199810%2959%3A2%3C156%3A%3AAID-AJH9%3E3.0.CO%3B2-X

A pharmacokinetic study of prednimustine as compared with prednisolone plus chlorambucil in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199810%2959%3A2%3C156%3A%3AAID-AJH9%3E3.0.CO%3B2-X

CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291096-8652%28199810%2959%3A2%3C156%3A%3AAID-AJH9%3E3.0.CO%3B2-X

10.1002/(SICI)1096-8652(199810)59:2<156::AID-AJH9>3.0.CO;2-X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9766801%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference